(YMAG) YieldMax Magnificent 7 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US88636J6423

YMAG: Shares, Underlying, ETFs, Instruments

The YieldMax™ Magnificent7 Fund of Option Income ETFs (YMAG) is a fund of funds ETF that invests primarily in seven Underlying YieldMax ETFs, providing a diversified portfolio of option income-generating strategies. By investing in other ETFs rather than individual securities, YMAG offers a unique approach to income generation.

YMAGs non-diversified nature means it can concentrate its investments in the seven Underlying YieldMax ETFs, potentially amplifying returns. The funds ability to invest directly in the same instruments held by the Underlying YieldMax ETFs for tax purposes adds a layer of flexibility to its investment strategy.

Analyzing the , we can see that YMAGs last price is $15.07, with a 20-day SMA of $14.34 and a 50-day SMA of $14.45, indicating a potential bullish trend. The 200-day SMA at $15.31 suggests that the fund is currently trading below its long-term average. The ATR of 0.52, or 3.43%, indicates moderate volatility. Given these technical indicators, a potential forecast is that YMAG may continue to trade within a narrow range, with a potential breakout above $15.31.

Considering the , YMAGs AUM of $300.77M USD suggests a relatively modest size, which could be both a blessing and a curse. On one hand, it allows for more agile investment decisions; on the other, it may limit the funds ability to invest in a wide range of assets. As the fund continues to grow, its ability to generate income through option strategies will be crucial to its success.

Combining both technical and fundamental analysis, a potential forecast for YMAG is that it may experience a moderate increase in price, potentially reaching $16.50 within the next 6-12 months, driven by its income-generating strategies and potential growth in AUM. However, this forecast is contingent upon the continued performance of the Underlying YieldMax ETFs and overall market conditions.

Additional Sources for YMAG ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

YMAG ETF Overview

Market Cap in USD 322m
Category Large Blend
TER 1.28%
IPO / Inception 2024-01-29

YMAG ETF Ratings

Growth Rating 39.3
Fundamental -
Dividend Rating 37.1
Rel. Strength 0.05
Analysts -
Fair Price Momentum 17.76 USD
Fair Price DCF -

YMAG Dividends

Dividend Yield 12m 48.00%
Yield on Cost 5y 61.25%
Annual Growth 5y -31.69%
Payout Consistency 100.0%
Payout Ratio %

YMAG Growth Ratios

Growth Correlation 3m 76.7%
Growth Correlation 12m 27.8%
Growth Correlation 5y 69%
CAGR 5y 22.60%
CAGR/Max DD 5y 0.87
Sharpe Ratio 12m 1.26
Alpha -0.77
Beta 1.114
Volatility 20.12%
Current Volume 694.8k
Average Volume 20d 727.1k
What is the price of YMAG shares?
As of June 15, 2025, the stock is trading at USD 15.08 with a total of 694,793 shares traded.
Over the past week, the price has changed by +0.39%, over one month by +2.55%, over three months by +12.49% and over the past year by +11.52%.
Is YieldMax Magnificent 7 a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, YieldMax Magnificent 7 (NYSE ARCA:YMAG) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.26 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of YMAG is around 17.76 USD . This means that YMAG is currently undervalued and has a potential upside of +17.77% (Margin of Safety).
Is YMAG a buy, sell or hold?
YieldMax Magnificent 7 has no consensus analysts rating.
What are the forecasts for YMAG share price target?
According to our own proprietary Forecast Model, YMAG YieldMax Magnificent 7 will be worth about 20.5 in June 2026. The stock is currently trading at 15.08. This means that the stock has a potential upside of +35.68%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 20.5 35.7%